Related Experiment Video
Updated: May 13, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Long-term management of Kawasaki disease: implications for the adult patient
Cedric Manlhiot1, Elizabeth Niedra, Brian W McCrindle
1Labatt Family Heart Centre, Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
Kawasaki disease (KD) patients with large or giant coronary artery aneurysms (CAA) require specialized follow-up. Current management protocols appear appropriate, but future research should explore KD
Area of Science:
- Cardiology
- Pediatric Rheumatology
- Vascular Medicine
Background:
- Kawasaki disease (KD) can lead to coronary artery complications, ranging from no involvement to giant coronary artery aneurysms (CAA).
- Current long-term management protocols for KD are based on the degree of coronary artery involvement.
- Recent suggestions propose that all KD patients may be at risk for severe long-term cardiac complications, necessitating a review of current protocols.
Purpose of the Study:
- To evaluate the current evidence regarding long-term cardiac risks in Kawasaki disease patients.
- To assess the adequacy of existing long-term management protocols for Kawasaki disease.
- To determine the need for modifications in follow-up strategies for adult KD survivors.
Main Methods:
- Review of available evidence on long-term cardiac complications in Kawasaki disease.
- Analysis of risk stratification based on coronary artery aneurysm (CAA) presence and size.
- Consideration of the influence of KD on the atherosclerotic process.
Main Results:
- Patients with multiple large or giant CAA face substantial long-term cardiac risks and require specialized follow-up.
- No increased risk of severe long-term cardiac complications has been reported for patients with transient or no CAA.
- Existing long-term management protocols seem appropriately calibrated to the current level of risk.
Conclusions:
- Current evidence supports specialized long-term follow-up for KD patients with significant CAA.
- There is insufficient evidence to mandate long-term specialized follow-up for patients without CAA.
- Future studies should investigate KD's impact on atherosclerosis, and revised protocols should include noninvasive imaging and risk factor management.
Abstract:
Coronary artery complications from Kawasaki disease (KD) range from no involvement to giant coronary artery aneurysms (CAA). Current long-term management protocols are calibrated to the degree of maximal and current coronary artery involvement reflecting the known likelihood of severe long-term cardiac complications. It has recently been suggested that all KD patients may be at potential risk of severe long-term cardiac complications. If this assertion was to be confirmed, current follow-up protocols would need to be extensively modified, with important implications both for the growing adult population with a previous history of KD and for the healthcare system. Based on the available evidence, patients with multiple large and/or giant CAA are at substantial risk of severe long-term cardiac complications and should have regular specialized follow-up. Patients with transient or no CAA have not been reported to be at risk of severe long-term cardiac complications. The influence of KD on the atherosclerotic process remains suboptimally defined, and should be the focus of future studies. Heightened cardiovascular risk factor surveillance and management is recommended regardless of coronary artery involvement. Based on the currently available evidence, existing long-term management protocols seem to be appropriately calibrated to the level of risk. Revised long-term management protocols should incorporate newer, noninvasive imaging methods and intensive management of atherosclerotic risk. There is insufficient evidence at this time to mandate long-term specialized follow-up and invasive testing for patients who have not had CAA.
Related Concept Videos
Myocarditis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease IV: Nursing Management
Mitral Stenosis III: Medical Management